Advisor Group Holdings, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$1.52 - $2.8 $1,520 - $2,800	-1,000 Reduced 18.9%	4,292 $9,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.54 $21 - $40	-16 Reduced 0.3%	5,292 $13,000
Q4 2022 Feb 10, 2023	BUY	$1.67 - $2.51 $861 - $1,295	516 Added 10.77%	5,308 $9,000
Q1 2022 May 04, 2022	SELL	$2.94 - $4.77 $19,162 - $31,090	-6,518 Reduced 57.63%	4,792 $14,000
Q3 2021 Nov 05, 2021	SELL	$4.7 - $7.24 $10,246 - $15,783	-2,180 Reduced 16.16%	11,310 $54,000
Q2 2021 Aug 02, 2021	SELL	$6.81 - $10.93 $22,677 - $36,396	-3,330 Reduced 19.8%	13,490 $93,000
Q1 2021 May 13, 2021	BUY	$6.14 - $8.31 $2,456 - $3,324	400 Added 2.44%	16,820 $120,000
Q4 2020 Feb 10, 2021	BUY	$4.58 - $7.14 $39,342 - $61,332	8,590 Added 109.71%	16,420 $103,000
Q3 2020 Nov 12, 2020	BUY	$4.19 - $6.69 $2,933 - $4,683	700 Added 9.82%	7,830 $42,000
Q1 2020 May 18, 2020	BUY	$2.67 - $4.97 $19,037 - $35,436	7,130 New	7,130 $23,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.